Log in

Regulation of PGE2 Pathway During Cerebral Ischemia Reperfusion Injury in Rat

  • Original Research
  • Published:
Cellular and Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Stroke is an acute central nervous system disease with high morbidity and mortality rate. Cerebral ischemia reperfusion (I/R) injury is easily induced during the development or treatment of stroke and subsequently leads to more serious brain damage. Prostaglandin E2 (PGE2) is one of the most important inflammatory mediators in the brain and contributes to both physiological and pathophysiological functions. It may be upregulated and subsequently plays a key role in cerebral ischemia reperfusion injury. The synthesis and degradation of PGE2 is an extremely complex process, with multiple key stages and molecules. However, there are few comprehensive and systematic studies conducted to investigate the synthesis and degradation of PGE2 during cerebral I/R injury, which is what we want to demonstrate. In this study, qRT-PCR and immunoblotting demonstrated that the key enzymes in PGE2 synthesis, including COX-1, COX-2, mPGES-1 and mPGES-2, were upregulated during cerebral I/R injury, but 15-PGDH, the main PGE2 degradation enzyme, was downregulated. In addition, two of PGE2 receptors, EP3 and EP4, were also increased. Meanwhile, immunohistochemistry demonstrated the localization of these molecules in ischemic areas, including cortex, striatum and hippocampus, and reflected their expression patterns in different regions. Combining the results of PCR, Western blotting and immunohistochemistry, we can determine where the increase or decrease of these molecules occurs. Overall, these results further indicate a possible pathway that mediates enhanced production of PGE2, and thus that may impact production of inflammatory cytokines including IL-1β and TNF-α during cerebral I/R injury.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Allen CL, Bayraktutan U (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4(6):461–470. https://doi.org/10.1111/j.1747-4949.2009.00387.x

    Article  CAS  PubMed  Google Scholar 

  • Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. Febs j 276(1):13–26. https://doi.org/10.1111/j.1742-4658.2008.06766.x

    Article  CAS  PubMed  Google Scholar 

  • Anrather J, Iadecola C (2016) Inflammation and Stroke: An Overview. Neurotherapeutics 13(4):661–670. https://doi.org/10.1007/s13311-016-0483-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ashwal S, Tone B, Tian HR, Cole DJ, Pearce WJ (1998) Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion. Stroke 29 (5):1037–1046; discussion 1047

  • Basbaum AI, Bautista DM, Scherrer G, Julius D (2009) Cellular and molecular mechanisms of pain. Cell 139(2):267–284. https://doi.org/10.1016/j.cell.2009.09.028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Caggiano AO, Kraig RP (1999) Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production. J Neurochem 72(2):565–575. https://doi.org/10.1046/j.1471-4159.1999.0720565.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Calvello R, Panaro MA, Carbone ML, Cianciulli A, Perrone MG, Vitale P, Malerba P, Scilimati A (2012) Novel selective COX-1 inhibitors suppress neuroinflammatory mediators in LPS-stimulated N13 microglial cells. Pharmacol Res 65(1):137–148. https://doi.org/10.1016/j.phrs.2011.09.009

    Article  CAS  PubMed  Google Scholar 

  • Cha YI, Solnica-Krezel L, DuBois RN (2006) Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins. Dev Biol 289(2):263–272. https://doi.org/10.1016/j.ydbio.2005.10.013

    Article  CAS  PubMed  Google Scholar 

  • Chen LF, Tian YF, Lin CH, Huang LY, Niu KC, Lin MT (2014) Repetitive hyperbaric oxygen therapy provides better effects on brain inflammation and oxidative damage in rats with focal cerebral ischemia. J Formos Med Assoc 113(9):620–628. https://doi.org/10.1016/j.jfma.2014.03.012

    Article  CAS  PubMed  Google Scholar 

  • Choi SH, Aid S, Bosetti F (2009) The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30(4):174–181. https://doi.org/10.1016/j.tips.2009.01.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dalvi S, Nguyen HH, On N, Mitchell RW, Aukema HM, Miller DW, Hatch GM (2015) Exogenous arachidonic acid mediates permeability of human brain microvessel endothelial cells through prostaglandin E2 activation of EP3 and EP4 receptors. J Neurochem 135(5):867–879. https://doi.org/10.1111/jnc.13117

    Article  CAS  PubMed  Google Scholar 

  • DeMars KM, McCrea AO, Siwarski DM, Sanz BD, Yang C, Candelario-Jalil E (2018) Protective Effects of L-902,688, a Prostanoid EP4 Receptor Agonist, against Acute Blood-Brain Barrier Damage in Experimental Ischemic Stroke. Front Neurosci 12:89. https://doi.org/10.3389/fnins.2018.00089

    Article  PubMed  PubMed Central  Google Scholar 

  • Eltzschig HK, Eckle T (2011) Ischemia and reperfusion–from mechanism to translation. Nat Med 17(11):1391–1401. https://doi.org/10.1038/nm.2507

    Article  CAS  PubMed  Google Scholar 

  • Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, Abyu GY, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Akinyemi RO, Alabed S, Al-Raddadi R, Alvis-Guzman N, Amare AT, Ansari H, Anwari P, Ärnlöv J, Asayesh H, Asgedom SW, Atey TM, Avila-Burgos L, Frinel E, Avokpaho GA, Azarpazhooh MR, Barac A, Barboza M, Barker-Collo SL, Bärnighausen T, Bedi N, Beghi E, Bennett DA, Bensenor IM, Berhane A, Betsu BD, Bhaumik S, Birlik SM, Biryukov S, Boneya DJ, Bulto LNB, Carabin H, Casey D, Castañeda-Orjuela CA, Catalá-López F, Chen H, Chitheer AA, Chowdhury R, Christensen H, Dandona L, Dandona R, de Veber GA, Dharmaratne SD, Do HP, Dokova K, Dorsey ER, Ellenbogen RG, Eskandarieh S, Farvid MS, Fereshtehnejad S-M, Fischer F, Foreman KJ, Geleijnse JM, Gillum RF, Giussani G, Goldberg EM, Gona PN, Goulart AC, Gugnani HC, Gupta R, Hachinski V, Gupta R, Hamadeh RR, Hambisa M, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Heydarpour P, Hotez PJ, Jakovljevic MB, Javanbakht M, Jeemon P, Jonas JB, Kalkonde Y, Kandel A, Karch A, Kasaeian A, Kastor A, Keiyoro PN, Khader YS, Khalil IA, Khan EA, Khang Y-H, Tawfih A, Khoja A, Khubchandani J, Kulkarni C, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kosen S, Kravchenko M, Krishnamurthi RV, Defo BK, Kumar GA, Kumar R, Kyu HH, Larsson A, Lavados PM, Li Y, Liang X, Liben ML, Lo WD, Logroscino G, Lotufo PA, Loy CT, Mackay MT, El Razek HMA, El Razek MMA, Majeed A, Malekzadeh R, Manhertz T, Mantovani LG, Massano J, Mazidi M, McAlinden C, Mehata S, Mehndiratta MM, Memish ZA, Mendoza W, Mengistie MA, Mensah GA, Meretoja A, Mezgebe HB, Miller TR, Mishra SR, Ibrahim NM, Mohammadi A, Mohammed KE, Mohammed S, Mokdad AH, Moradi-Lakeh M, Velasquez IM, Musa KI, Naghavi M, Ngunjiri JW, Nguyen CT, Nguyen G, Le Nguyen Q, Nguyen TH, Nichols E, Ningrum DNA, Nong VM, Norrving B, Noubiap JJN, Ogbo FA, Owolabi MO, Pandian JD, Parmar PG, Pereira DM, Petzold M, Phillips MR, Piradov MA, Poulton RG, Pourmalek F, Qorbani M, Rafay A, Rahman M, Rahman MH, Rai RK, Rajsic S, Ranta A, Rawaf S, Renzaho AMN, Rezai MS, Roth GA, Roshandel G, Rubagotti E, Sachdev P, Safiri S, Sahathevan R, Sahraian MA, Samy AM, Santalucia P, Santos IS, Sartorius B, Satpathy M, Sawhney M, Saylan MI, Sepanlou SG, Shaikh MA, Shakir R, Shamsizadeh M, Sheth KN, Shigematsu M, Shoman H, Silva DAS, Smith M, Sobngwi E, Sposato LA, Stanaway JD, Stein DJ, Steiner TJ, Stovner LJ, Abdulkader RS, Ei Szoeke C, Tabarés-Seisdedos R, Tanne D, Theadom AM, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Truelsen T, Tuem KB, Ukwaja KN, Uthman OA, Varakin YY, Vasankari T, Venketasubramanian N, Vlassov VV, Wadilo F, Wakayo T, Wallin MT, Weiderpass E, Westerman R, Wijeratne T, Wiysonge CS, Woldu MA, Wolfe CDA, Xavier D, Xu G, Yano Y, Yimam HH, Yonemoto N, Yu C, Zaidi Z, El Sayed ZM, Zunt JR, Murray CJL, Vos T (2017) Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet Neurology 16(11):877–897. https://doi.org/10.1016/s1474-4422(17)30299-5

    Article  Google Scholar 

  • Goulet JL, Pace AJ, Key ML, Byrum RS, Nguyen M, Tilley SL, Morham SG, Langenbach R, Stock JL, McNeish JD, Smithies O, Coffman TM, Koller BH (2004) E-prostanoid-3 receptors mediate the proinflammatory actions of prostaglandin E2 in acute cutaneous inflammation. J Immunol 173(2):1321–1326. https://doi.org/10.4049/jimmunol.173.2.1321

    Article  CAS  PubMed  Google Scholar 

  • Hankey GJ (2017) Stroke. The Lancet 389(10069):641–654. https://doi.org/10.1016/s0140-6736(16)30962-x

    Article  Google Scholar 

  • Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME (2001) Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc Natl Acad Sci USA 98(3):1294–1299. https://doi.org/10.1073/pnas.98.3.1294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikeda-Matsuo Y, Ota A, Fukada T, Uematsu S, Akira S, Sasaki Y (2006) Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci USA 103(31):11790–11795. https://doi.org/10.1073/pnas.0604400103

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikeda-Matsuo Y, Tanji H, Narumiya S, Sasaki Y (2011) Inhibition of prostaglandin E2 EP3 receptors improves stroke injury via anti-inflammatory and anti-apoptotic mechanisms. J Neuroimmunol 238(1–2):34–43. https://doi.org/10.1016/j.jneuroim.2011.06.014

    Article  CAS  PubMed  Google Scholar 

  • Justin A, Sathishkumar M, Sudheer A, Shanthakumari S, Ramanathan M (2014) Non-hypotensive dose of telmisartan and nimodipine produced synergistic neuroprotective effect in cerebral ischemic model by attenuating brain cytokine levels. Pharmacol Biochem Behav 122:61–73. https://doi.org/10.1016/j.pbb.2014.03.009

    Article  CAS  PubMed  Google Scholar 

  • Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL (2007) Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog Lipid Res 46(2):108–125. https://doi.org/10.1016/j.plipres.2007.01.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kapitanovic Vidak H, Catela Ivkovic T, Vidak Z, Kapitanovic S (2017) COX-1 and COX-2 polymorphisms in susceptibility to cerebral palsy in very preterm infants. Mol Neurobiol 54(2):930–938. https://doi.org/10.1007/s12035-016-9713-9

    Article  CAS  PubMed  Google Scholar 

  • Kempski O, Shohami E, von Lubitz D, Hallenbeck JM, Feuerstein G (1987) Postischemic production of eicosanoids in gerbil brain. Stroke 18(1):111–119

    Article  CAS  Google Scholar 

  • Kumazawa T, Mizumura K, Koda H (1993) Involvement of EP3 subtype of prostaglandin E receptors in PGE2-induced enhancement of the bradykinin response of nociceptors. Brain Res 632(1–2):321–324

    Article  CAS  Google Scholar 

  • Legler DF, Bruckner M, Uetz-von Allmen E, Krause P (2010) Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 42(2):198–201. https://doi.org/10.1016/j.biocel.2009.09.015

    Article  CAS  PubMed  Google Scholar 

  • Liu Y, Jia Z, Sun Y, Zhou L, Downton M, Chen R, Zhang A, Yang T (2014) Postnatal regulation of 15-hydroxyprostaglandin dehydrogenase in the rat kidney. Am J Physiol Renal Physiol 307(4):F388–395. https://doi.org/10.1152/ajprenal.00512.2013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262

    Article  CAS  PubMed  Google Scholar 

  • McCullough L, Wu L, Haughey N, Liang X, Hand T, Wang Q, Breyer RM, Andreasson K (2004) Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia. J Neurosci 24(1):257–268. https://doi.org/10.1523/jneurosci.4485-03.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G (1997) Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19(2):152–160

    Article  CAS  Google Scholar 

  • Radi ZA, Khan NK (2006) Effects of cyclooxygenase inhibition on the gastrointestinal tract. Exp Toxicol Pathol 58(2–3):163–173. https://doi.org/10.1016/j.etp.2006.06.004

    Article  CAS  PubMed  Google Scholar 

  • Saleem S, Kim YT, Maruyama T, Narumiya S, Dore S (2009) Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia. J Neuroimmunol 208(1–2):87–93. https://doi.org/10.1016/j.jneuroim.2009.01.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shi J, Johansson J, Woodling NS, Wang Q, Montine TJ, Andreasson K (2010) The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity. J Immunol 184(12):7207–7218. https://doi.org/10.4049/jimmunol.0903487

    Article  CAS  PubMed  Google Scholar 

  • Shimizu T, Tanaka K, Nakamura K, Taniuchi K, Yawata T, Higashi Y, Ueba T, Dimitriadis F, Shimizu S, Yokotani K, Saito M (2014) Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat. Neuropharmacology 82:19–27. https://doi.org/10.1016/j.neuropharm.2014.03.005

    Article  CAS  PubMed  Google Scholar 

  • Sugimoto Y, Narumiya S (2007) Prostaglandin E receptors. The Journal of biological chemistry 282(16):11613–11617. https://doi.org/10.1074/jbc.R600038200

    Article  CAS  PubMed  Google Scholar 

  • Tai HH, Cho H, Tong M, Ding Y (2006) NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des 12(8):955–962

    Article  CAS  Google Scholar 

  • Tai HH, Ensor CM, Tong M, Zhou H, Yan F (2002) Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 68–69:483–493

    Article  Google Scholar 

  • Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M, Ito S, Watanabe K (2002) Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 291(4):884–889. https://doi.org/10.1006/bbrc.2002.6531

    Article  CAS  PubMed  Google Scholar 

  • Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I (2000) Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. The Journal of biological chemistry 275(42):32775–32782. https://doi.org/10.1074/jbc.M003504200

    Article  CAS  PubMed  Google Scholar 

  • Xu J, Xu Z, Yan A (2017) Prostaglandin E2 EP4 Receptor Activation Attenuates Neuroinflammation and Early Brain Injury Induced by Subarachnoid Hemorrhage in Rats. Neurochem Res 42(4):1267–1278. https://doi.org/10.1007/s11064-016-2168-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (No. 81571880, 81373147, 30901555, 30972870, 81360080, 81671895, 81471897 and 81671895) and Natural Science Foundation of Hunan Province (No. 2016JJ2157). All the funding bodies funded in the study design, collection, analysis, interpretation of data and writing the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

YL and JZ designed and directed the project. YX and KL performed the experiments. YX, YL, KL, SM, CL and CW analyzed the data. All authors discussed the results and contributed to the final manuscript. Yunfei Xu wrote the manuscript.

Corresponding authors

Correspondence to Ying Liu or Jie Zhao.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted by Experimental Animal Center of Central South University (Changsha, China), No: 2018sydw0222.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, Y., Liu, Y., Li, K. et al. Regulation of PGE2 Pathway During Cerebral Ischemia Reperfusion Injury in Rat. Cell Mol Neurobiol 41, 1483–1496 (2021). https://doi.org/10.1007/s10571-020-00911-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10571-020-00911-5

Keywords

Navigation